ArticlePharmacoepidemiology and drug safety2025

Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study.

Sarah Ruth Hurwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.